TANZEN MEDICAL, INC.
Medtech · Private
Ankle-worn wearable device with mobile app that measures leg movements during sleep to diagnose Restless Legs Syndrome in Alzheimer's patients
- Grants
- $1.3M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.5M
- 2 awards · Defense
- #256 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: In-home Monitoring of Sleep Fragmentation and Micro-Arousals by Characterizing Leg Movements | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Patients with Alzheimer's Disease | $500,709 | |
| Federal grant | Department of Health and Human Services · Phase I · RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Patients with Alzheimer's Disease | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase I · RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Pediatric Patients with Attention Deficit/Hyperactivity Disorder | $486,552 | |
| Federal contract | Department of Defense · Tanzen Medical Dha SBIR Phase I Guardian Sleep Assessment System: Detecting Microarousals Associated With Leg Movements During Sleep | $249,777 | |
| Federal contract | Department of Defense · Defense Health Agency Small Business Innovation Research Phase II Research | $1,267,096 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 253 | SAGE SCIENCE, INC. | $1.5M | $9.9M |
| 254 | Ekso Bionics, Inc. | $1.5M | $14M |
| 255 | Far UV Technologies Inc | $1.5M | $1.6M |
| 256 | TANZEN MEDICAL, INC. | $1.5M | — |
| 257 | MICRO-LEADS INC | $1.5M | — |
| 258 | Micro-Leads,Inc. | $1.5M | — |
| 259 | OPSENS INC | $1.5M | $99K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.